Novozymes and Terranol to market advanced biofuel yeast
Novozymes and Terranol, a Denmark-based biotechnology company specialized in yeast, announced an agreement that will ensure the final optimization of the Terranol C5 yeast strain and give Novozymes the rights to register and market Terranol’s C5 yeast technology. C5 yeast is an essential component in the production of cellulosic ethanol, and the partnership will allow Novozymes to speed up global rollout of Terranol’s yeast to customers in the cellulosic ethanol industry. Wide availability of a high-performing and cost-efficient yeast will enable the nascent industry to fast-track the transition from today’s demonstration-scale production to large-scale commercialization.
“We want to make sure there are no biotech-related hurdles to the creation of a cellulosic ethanol industry,” says Poul Ruben Andersen, Vice President Bioenergy at Novozymes. “Terranol’s C5 yeast is currently one of the best strains developed, and by getting it registered and marketed around the world, we can help make it available to the biofuel industry. This will provide a higher degree of certainty in the commercialization of cellulosic ethanol.”
“With our combined R&D capabilities we can ensure the final optimization of the strain in order to achieve maximum economic performance for our cellulosic ethanol customers,” says Claus Crone Fuglsang, Vice President R&D at Novozymes.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Hesperion announces the opening of its Russian Moscow Office

Takara Bio and Eppendorf cooperate - Automation of Takara Bio’s Chemistries on Eppendorf’s Automated Pipetting Systems for Significantly Higher Efficiency
New genetic links to MS also play roles in other autoimmune diseases

Dust mite allergens trigger inflammatory responses - Dust mite allergens activate the pulmonary immune system, thereby triggering allergies
